Carsten Goessl

14.5k total citations · 6 hit papers
114 papers, 9.7k citations indexed

About

Carsten Goessl is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Carsten Goessl has authored 114 papers receiving a total of 9.7k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Oncology, 64 papers in Pulmonary and Respiratory Medicine and 27 papers in Molecular Biology. Recurrent topics in Carsten Goessl's work include Prostate Cancer Treatment and Research (41 papers), Bone health and treatments (38 papers) and PARP inhibition in cancer therapy (31 papers). Carsten Goessl is often cited by papers focused on Prostate Cancer Treatment and Research (41 papers), Bone health and treatments (38 papers) and PARP inhibition in cancer therapy (31 papers). Carsten Goessl collaborates with scholars based in United States, Germany and United Kingdom. Carsten Goessl's co-authors include Fred Saad, Wenting Wu, Karim Fizazi, Mark E. Robson, Norikazu Masuda, Binghe Xu, Seock‐Ah Im, Elżbieta Senkus, Pierfranco Conté and Anne Armstrong and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Carsten Goessl

112 papers receiving 9.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation

2017 2.2k citations Mark E. Robson, Seock‐Ah Im et al. New England Journal of Medicine profile →
Olaparib for Metastatic Castration-Resistant Prostate Cancer

2020 1.4k citations Johann S. de Bono, Joaquı́n Mateo et al. New England Journal of Medicine profile →
Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study

2011 1.4k citations Karim Fizazi, Michael A. Carducci et al. profile →
Denosumab in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer

2009 786 citations Fred Saad, Carsten Goessl et al. New England Journal of Medicine profile →
OlympiAD final overall survival and tolerability results: Olaparib versus chemotherapy treatment of physician’s choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer

2019 497 citations Mark E. Robson, Nadine Tung et al. Annals of Oncology profile →
Olaparib combined with abiraterone in patients with metastatic castration-resistant prostate cancer: a randomised, double-blind, placebo-controlled, phase 2 trial

2018 281 citations Noel W. Clarke, Paweł Wiechno et al. The Lancet Oncology profile →

Peers

Countries citing papers authored by Carsten Goessl

Since Specialization

Citations

This map shows the geographic impact of Carsten Goessl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carsten Goessl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carsten Goessl more than expected).

Fields of papers citing papers by Carsten Goessl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carsten Goessl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carsten Goessl. The network helps show where Carsten Goessl may publish in the future.

Co-authorship network of co-authors of Carsten Goessl

This figure shows the co-authorship network connecting the top 25 collaborators of Carsten Goessl. A scholar is included among the top collaborators of Carsten Goessl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carsten Goessl. Carsten Goessl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Olaparib for Metastatic Castration-Resistant Prostate Cancer breakdown → 2020 ·New England Journal of Medicine ·Johann S. de Bono, Joaquı́n Mateo, Karim Fizazi, Fred Saad, Neal D. Shore, Shahneen Sandhu, Kim N., Oliver Sartor, Neeraj Agarwal, David Olmos, Antoine Thiery-Vuillemin, Przemyslaw Twardowski, Niven Mehra, Carsten Goessl, Jinyu Kang, Joseph E. Burgents, Wenting Wu, Alexander Kohlmann, Carrie A. Adelman, Maha Hussain	1397
2	OlympiAD final overall survival and tolerability results: Olaparib versus chemotherapy treatment of physician’s choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer breakdown → 2019 ·Annals of Oncology ·Mark E. Robson, Nadine Tung, Pierfranco Conté, Seock‐Ah Im, Elżbieta Senkus, Binghe Xu, Norikazu Masuda, Suzette Delaloge, W. Li, Anne Armstrong, Weiwen Wu, Carsten Goessl, Sarah Runswick, Susan M. Domchek	497
3	Patient-reported outcomes in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer receiving olaparib versus chemotherapy in the OlympiAD trial 2019 ·European Journal of Cancer ·Mark E. Robson, Kathryn J. Ruddy, Seock‐Ah Im, Elżbieta Senkus, Binghe Xu, Susan M. Domchek, Norikazu Masuda, Wei Li, Nadine Tung, Anne Armstrong, Suzette Delaloge, Wendy Bannister, Carsten Goessl, Arnold Degboe, Robert Hettle, Pierfranco Conté	57
4	Olaparib combined with abiraterone in patients with metastatic castration-resistant prostate cancer: a randomised, double-blind, placebo-controlled, phase 2 trial breakdown → 2018 ·The Lancet Oncology ·Noel W. Clarke, Paweł Wiechno, B. Yа. Alekseev, Núria Sala, Robert H. Jones, Ivo Kocák, Vincenzo Emanuele Chiurì, Jacek Jassem, Aude Fléchon, Charles H. Redfern, Carsten Goessl, Joseph E. Burgents, Robert Kozarski, Darren Hodgson, Maria Learoyd, Fred Saad	281
5	Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation breakdown → 2017 ·New England Journal of Medicine ·Mark E. Robson, Seock‐Ah Im, Elżbieta Senkus, Binghe Xu, Susan M. Domchek, Norikazu Masuda, Suzette Delaloge, Wěi Li, Nadine Tung, Anne Armstrong, Wenting Wu, Carsten Goessl, Sarah Runswick, Pierfranco Conté	2156
6	OlympiA: A randomized phase III trial of olaparib as adjuvant therapy in patients with high-risk HER2-negative breast cancer (BC) and a germline BRCA1/2 mutation (gBRCAm) 2017 ·Annals of Oncology ·Andrew Tutt, Bella Kaufman, Judy E. Garber, RD Gelber, Eleanor McFadden, Carsten Goessl, Giuseppe Viale, Charles E. Geyer, Dimitrios Zardavas, Amal Arahmani, Debora Fumagalli, Evandro de Azambuja, Noam Pondé, Pia Herbolsheimer, Weiwen Wu, (unknown), Priya Rastogi	16
7	OlympiAD: Health-related quality of life (HRQoL) in patients with HER2-negative metastatic breast cancer (mBC) and a germline BRCA mutation (gBRCAm) receiving olaparib monotherapy vs standard single-agent chemotherapy treatment of physician’s choice (TPC) 2017 ·Annals of Oncology ·Mark E. Robson, Kathryn J. Ruddy, S-A. Im, Elżbieta Senkus, Binghe Xu, S. M. Domchek, Norikazu Masuda, Suzette Delaloge, W. Li, Nadine Tung, Anne Armstrong, Weiwen Wu, Carsten Goessl, Arnold Degboe, Pierfranco Conté	4
8	OlympiAD: Further efficacy outcomes in patients with HER2-negative metastatic breast cancer and a germline BRCA mutation receiving olaparib monotherapy vs standard single-agent chemotherapy treatment of physician’s choice 2017 ·Annals of Oncology ·Suzette Delaloge, Pierfranco Conté, S-A. Im, Elżbieta Senkus, Binghe Xu, Susan M. Domchek, Norikazu Masuda, W. Li, Nadine Tung, Anne Armstrong, Weiwen Wu, Carsten Goessl, Sarah Runswick, Mark E. Robson	2
9	Bone-related Parameters are the Main Prognostic Factors for Overall Survival in Men with Bone Metastases from Castration-resistant Prostate Cancer 2014 ·European Urology ·Karim Fizazi, Christophe Massard, Matthew R. Smith, Michael Rader, Janet E. Brown, Piotr Milecki, Neal D. Shore, Stéphane Oudard, Lawrence I. Karsh, Michael A. Carducci, Ronaldo Damião, Huei Wang, Wendy Ying, Carsten Goessl	109
10	Effects of Denosumab versus Zoledronic Acid in Patients with Castration-Resistant Prostate Cancer and Bone Metastases 2012 ·Neal D. Shore, Carsten Goessl	1
11	Clinical development of anti-RANKL therapies for treatment and prevention of bone metastasis 2010 ·Bone ·Allan Lipton, Carsten Goessl	57
12	Hyperphosphaturia after kidney transplantation in syngeneic rats: effects on nephrocalcinosis and bone metabolism? 2003 ·Transplantation Proceedings ·Bernd F. Straub, M. Müller, R. Heicappell, M. Schrader, Carsten Goessl, K. Miller	4
13	Diagnostic potential of circulating nucleic acids for oncology 2003 ·Expert Review of Molecular Diagnostics ·Carsten Goessl	18
14	DNA‐Based Detection of Prostate Cancer in Blood, Urine, and Ejaculates 2001 ·Annals of the New York Academy of Sciences ·Carsten Goessl, M. G. Müller, Rüdiger Heicappell, Hans Krause, Kurt Miller	111
15	Methylation-specific PCR (MSP) for detection of tumour DNA in the blood plasma and serum of patients with prostate cancer 2000 ·Prostate Cancer and Prostatic Diseases ·Carsten Goessl, M. Müller, K. Miller	15
16	Urodynamic Effects of Oral Oxybutynin Chloride in Children With Myelomeningocele and Detrusor Hyperreflexia 1998 ·Urology ·Carsten Goessl, Helmut H. Knispel, (unknown), (unknown), (unknown), K. Miller	42
17	An intronic germline transition in the HNPCC gene hMSH2 is associated with sporadic colorectal cancer 1997 ·European Journal of Cancer ·Carsten Goessl, Jens Plaschke, Steffen Pistorius, Matthias Hahn, Stephan Frank, Monika Hampl, Heike Görgens, R. Koch, Hans‐Detlev Saeger, Hans K. Schackert	33
18	Nitroxergic innervation of the human ureterovesical junction 1995 ·Urological Research ·Carsten Goessl, Zarko Grozdanovic, Helmut H. Knispel, H Wegner, Kenneth E. Miller	13
19	Differential induction of eicosanoid synthesis in monocytic cells treated with retinoic acid and 1,25-dihydroxy-vitamin D3 1994 ·Prostaglandins ·Carsten Goessl, (unknown), Ruediger Volk, (unknown), Christian Weber, Alois Sellmayer	17
20	Nitric oxide mediates relaxation in rabbit and human corpus cavernosum smooth muscle 1992 ·Urological Research ·Helmut H. Knispel, Carsten Goessl, Roland Beckmann	56

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact